What changed at QST in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 166 of 170 of this archive, newest first.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Weight loss reduces bone mineral density at load-bearing sites. Whether that translates into fractures in this population is unmeasured.
Selectivity, potency and efficacy are three different measurements. The trade routinely reports none of them.
The Journal does not treat a badge as evidence and states so wherever it reports one.
A proper account of an operation that existed, and of what closing it cost.
The evidence base is thin and the document says so, which is to its credit.
Follow the resin, not the catalogue.
Reported from the analysis, not from a warning notice.
Every instrument specification quoted in an advertisement is a best case obtained on a calibration mixture, not on a submitted vial.
The route did not close because of a rule about peptides.
A proper account of an operation that existed, and of what closing it cost.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Reported from the analysis, not from a warning notice.
Cost is the modal reason for discontinuation in every dataset we have seen, and it is absent from the clinical literature.
A rotation scheme that is too complicated will not be followed. We describe the simple ones that are.
Reported from the sessions, and from the two hours afterwards.
The report states the gradient, the wavelength and the integration threshold, which is more than most.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The interval between manufacture and analysis is the most under-read figure on the page, and the one most likely to matter by the time a vial is opened.
Roughly four to seven per cent of trial participants discontinued for adverse events, mostly gastrointestinal, mostly during escalation. That is the empirical size of the…
The observation that closes a facility is rarely the dramatic one.
Reported from the analysis, not from a warning notice.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
A great deal of practice has grown up around intermittent schedules. The randomised evidence for any of them is, as far as the Journal can establish, nil.
What the Journal asks when a document arrives unsigned, and what the answers have been.
Efficacy was never the question in this appraisal. Duration of treatment was.
A proper account of an operation that existed, and of what closing it cost.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.